Jacquot, C. | IICIMED

Jacquot, C.

Publications

P173

Bioorg. Med. Chem. Lett. 2018, 28, 2250-2255.

Benzofuro[3,2-d]pyrimidines inspired from cercosporamide CaPkc1 inhibitor: synthesis and evaluation of fluconazole susceptibility restoration.

Dao, V.H. | Ourliac-Garnier, I. | Bazin, M.-A. | Jacquot, C. | Baratte, B. | Ruchaud, S. | Bach, S. | Grovel, O. | Le Pape, P. | Marchand, P.

doi: 10.1016/j.bmcl.2018.05.044

P138

Sci. Rep. 2015, 5:10356

 TP53 transcription factor to NEDD9/HEF1/Cas-L gene: potential targets in Non Small Cell Lung Cancer treatment.

Rousseau, B. | Jacquot, C. | Le Palabe, J. | Malleter, M. | Tomasoni, C. | Boutard, T. | Sakanyan, V. | Roussakis, C.

doi: 10.1038/srep10356

P111

J. Ocul. Pharmacol. Ther. 2012, 28, 299-306. 

Study of antiproliferative effects of synthetic substances against lens epithelial cell line (SRA01/04).

Malleter, M. | Jacquot, C. | Rousseau, B. | Tomasoni, C. | Ducourneau, D. | Tourette, P. | Pineau, A. | Roussakis, C.

P110

Gene, 2012, 506, 355-9.

miRNAs, a potential target in the treatment of Non-Small Cell Lung Carcinomas.

Malleter, M. | Jacquot, C. | Rousseau, B. | Tomasoni, C. | Jugé, M. | Pineau, A. | Sakanian, V. | Roussakis, C.

Autres publications scientifiques

Brevets

Thèse